Patents by Inventor Marion Kixmoeller

Marion Kixmoeller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of reducing concomitant infections in pigs with a PCV2 antigen
    Patent number: 8475805
    Abstract: The present invention relates to a method for reducing the percentage of concomitant infections in pigs or a herd of pigs caused by pathogens other than PCV2 comprising the step administering to said pig(s) an effective amount of PCV2 antigen or an immunogenic composition comprising PCV2 antigen. It also refers to a method for improving the resistance of pigs against concomitant infections with pathogens other than PCV2, comprising the step administering to said pig(s) an effective amount of PCV2 antigen or an immunogenic composition comprising PCV2 antigen.
    Type: Grant
    Filed: November 8, 2010
    Date of Patent: July 2, 2013
    Assignee: Boehringer Ingelheim Vetmedica, Inc.
    Inventors: Vicky Fachinger, Knut Elbers, Marion Kixmoeller
  • PROPHYLAXIS AND TREATMENT OF PRDC
    Publication number: 20130115236
    Abstract: The present invention relates to the use of an immunogenic composition comprising a porcine circovirus type 2 (PCV2) antigen for the prevention and treatment, including a reduction in the severity of, duration of, and manifestations of, porcine respiratory disease complex (PRDC) in animals, preferably in pigs.
    Type: Application
    Filed: December 28, 2012
    Publication date: May 9, 2013
    Applicant: Boehringer Ingelheim Vetmedica, Inc.
    Inventors: Vicky FACHINGER, Knut ELBERS, Marion KIXMOELLER, Francois-Xavier ORVEILLON, Isabelle FREIIN VON RICHTHOFEN, Axel LISCHEWSKI
  • PREVENTION AND TREATMENT OF SUB-CLINICAL PCVD
    Publication number: 20110182935
    Abstract: The present invention relates to the use of an immunogenic composition comprising a porcine circovirus type 2 (PCV2) antigen for the prevention and treatment of sub-clinical PCV2 infection in animals, preferably in pigs.
    Type: Application
    Filed: April 4, 2011
    Publication date: July 28, 2011
    Applicant: BOEHRINGER INGELHEIM VETMEDICA, INC.
    Inventors: Vicky Fachinger, Knut Elbers, Marion Kixmoeller, Francois-Xavier Orveillon, Isabelle von Richthofen, Axel Lischewski
  • TREATMENT OF PRDC IN PIGS
    Publication number: 20110129495
    Abstract: The present invention relates to the use of an immunogenic composition comprising a porcine circovirus type 2 (PCV2) antigen for the prevention and treatment, including a reduction in the severity of, duration of, and manifestations of, porcine respiratory disease complex (PRDC) in animals, preferably in pigs.
    Type: Application
    Filed: February 9, 2011
    Publication date: June 2, 2011
    Applicant: Boehringer Ingelheim Vetmedica, Inc.
    Inventors: Vicky Fachinger, Knut Elbers, Marion Kixmoeller, Francois-Xavier Orveillon, Isabelle von Richthofen, Axel Lischewski
  • Prevention and treatment of sub-clinical PCVD
    Patent number: 7943298
    Abstract: The present invention relates to the use of an immunogenic composition comprising a porcine circovirus type 2 (PCV2) antigen for the prevention and treatment of sub-clinical PCV2 infection in animals, preferably in pigs.
    Type: Grant
    Filed: February 13, 2008
    Date of Patent: May 17, 2011
    Assignee: Boehringer Ingelheim Vetmedica, Inc.
    Inventors: Vicky Fachinger, Knut Elbers, Marion Kixmoeller, Francois-Xavier Orveillon, Isabelle Von Richthofen, Axel Lischewski
  • TREATMENT OF PIGS WITH PCV2 ANTIGENT
    Publication number: 20110091499
    Abstract: The present invention relates to a method for the treatment or prophylaxis of a PCV2 infection or for reduction of clinical symptoms caused by or associated with a PCV2 infection in animals a) having anti-PCV2 antibodies and/or b) being young piglets of 1 to 22 days of age, comprising the step of administering an effective amount of a PCV2 antigen to that animal in need of such treatment. Preferably, those animals are pigs or young piglets.
    Type: Application
    Filed: December 14, 2007
    Publication date: April 21, 2011
    Applicant: BOEHRINGER INGELHEIM VETMEDICA, INC.
    Inventors: Vicky Fachinger, Knut Elbers, Axel Lischewski, Marion Kixmoeller, Francois-Xavier Orveillon, Isabelle Freiin Von Richthofen, Michael Piontkowski
  • Treatment of PRDC in pigs
    Patent number: 7914992
    Abstract: The present invention relates to the use of an immunogenic composition comprising a porcine circovirus type 2 (PCV2) antigen for the prevention and treatment, including a reduction in the severity of, duration of, and manifestations of, porcine respiratory disease complex (PRDC) in animals, preferably in pigs.
    Type: Grant
    Filed: January 3, 2008
    Date of Patent: March 29, 2011
    Assignee: Boehringer Ingelheim Vetmedica, Inc.
    Inventors: Vicky Fachinger, Knut Elbers, Marion Kixmoeller, Francois-Xavier Orveillon, Isabelle von Richthofen, Axel Lischewski
  • METHODS OF REDUCING CONCOMITANT INFECTIONS IN PIGS WITH A PCV2 ANTIGEN
    Publication number: 20110052629
    Abstract: The present invention relates to a method for reducing the percentage of concomitant infections in pigs or a herd of pigs caused by pathogens other than PCV2 comprising the step administering to said pig(s) an effective amount of PCV2 antigen or an immunogenic composition comprising PCV2 antigen. It also refers to a method for improving the resistance of pigs against concomitant infections with pathogens other than PCV2, comprising the step administering to said pig(s) an effective amount of PCV2 antigen or an immunogenic composition comprising PCV2 antigen.
    Type: Application
    Filed: November 8, 2010
    Publication date: March 3, 2011
    Applicant: Boehringer Ingelheim Vetmedica, Inc.
    Inventors: Vicky FACHINGER, Knut Elbers, Marion Kixmoeller
  • Reduction of concomitant infections in pigs by the use of PCV2 antigen
    Patent number: 7829274
    Abstract: The present invention relates to a method for reducing the percentage of concomitant infections in pigs or a herd of pigs caused by pathogens other than PCV2 comprising the step administering to said pig(s) an effective amount of PCV2 antigen or an immunogenic composition comprising PCV2 antigen. It also refers to a method for improving the resistance of pigs against concomitant infections with pathogens other than PCV2, comprising the step administering to said pig(s) an effective amount of PCV2 antigen or an immunogenic composition comprising PCV2 antigen.
    Type: Grant
    Filed: August 26, 2008
    Date of Patent: November 9, 2010
    Assignee: Boehringer Ingelheim Vetmedica, Inc.
    Inventors: Vicky Fachinger, Knut Elbers, Marion Kixmoeller
  • REDUCTION OF CONCOMITANT INFECTIONS IN PIGS BY THE USE OF PCV2 ANTIGEN
    Publication number: 20090098158
    Abstract: The present invention relates to a method for reducing the percentage of concomitant infections in pigs or a herd of pigs caused by pathogens other than PCV2 comprising the step administering to said pig(s) an effective amount of PCV2 antigen or an immunogenic composition comprising PCV2 antigen. It also refers to a method for improving the resistance of pigs against concomitant infections with pathogens other than PCV2, comprising the step administering to said pig(s) an effective amount of PCV2 antigen or an immunogenic composition comprising PCV2 antigen.
    Type: Application
    Filed: August 26, 2008
    Publication date: April 16, 2009
    Applicant: BOEHRINGER INGELHEIM VETMEDICA, INC.
    Inventors: Vicky Fachinger, Knut Elbers, Marion Kixmoeller
  • PREVENTION AND TREATMENT OF SUB-CLINICAL PCVD
    Publication number: 20090010954
    Abstract: The present invention relates to the use of an immunogenic composition comprising a porcine circovirus type 2 (PCV2) antigen for the prevention and treatment of sub-clinical PCV2 infection in animals, preferably in pigs.
    Type: Application
    Filed: February 13, 2008
    Publication date: January 8, 2009
    Applicant: BOEHRINGER INGELHEIM VETMEDICA, INC.
    Inventors: Vicky Fachinger, Knut Elbers, Marion Kixmoeller, Francois-Xavier Orveillon, Isabelle Von Richthofen, Axel Lischewski
  • TREATMENT OF PRDC IN PIGS
    Publication number: 20080305128
    Abstract: The present invention relates to the use of an immunogenic composition comprising a porcine circovirus type 2 (PCV2) antigen for the prevention and treatment, including a reduction in the severity of, duration of, and manifestations of, porcine respiratory disease complex (PRDC) in animals, preferably in pigs.
    Type: Application
    Filed: January 3, 2008
    Publication date: December 11, 2008
    Applicant: BOEHRINGER INGELHEIM VETMEDICA, INC.
    Inventors: Vicky Fachinger, Knut Elbers, Marion Kixmoeller, Francois-Xavier Orveillon, Isabelle von Richthofen, Axel Lischewski